In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Bioceres Crop Solutions Corp (NASDAQ: BIOX) closed the day trading at $1.49 down -1.32% from the previous closing price of $1.51. In other words, the price has decreased by -$1.32 from its previous closing price. On the day, 0.57 million shares were traded. BIOX stock price reached its highest trading level at $1.5379 during the session, while it also had its lowest trading level at $1.4301.
Ratios:
For a better understanding of BIOX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.61. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.94. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 10, 2025, Canaccord Genuity Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $2.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOX now has a Market Capitalization of 94583432 and an Enterprise Value of 366087264. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.37. Its current Enterprise Value per Revenue stands at 1.151 whereas that against EBITDA is 31.002.
Stock Price History:
The Beta on a monthly basis for BIOX is 0.47, which has changed by -0.75205255 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, BIOX has reached a high of $7.44, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -10.99%, while the 200-Day Moving Average is calculated to be -54.37%.
Shares Statistics:
Over the past 3-months, BIOX traded about 817.36K shares per day on average, while over the past 10 days, BIOX traded about 396090 shares per day. A total of 61.31M shares are outstanding, with a floating share count of 45.44M. Insiders hold about 28.14% of the company’s shares, while institutions hold 39.70% stake in the company. Shares short for BIOX as of 1764288000 were 1097879 with a Short Ratio of 1.34, compared to 1761868800 on 926526. Therefore, it implies a Short% of Shares Outstanding of 1097879 and a Short% of Float of 2.96.
Earnings Estimates
The dynamic stock of Bioceres Crop Solutions Corp (BIOX) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.16 and -$0.42 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is $0.05, with 1.0 analysts recommending between $0.05 and $0.05.
Revenue Estimates
3 analysts predict $107M in revenue for. The current quarter. It ranges from a high estimate of $113.1M to a low estimate of $96M. As of. The current estimate, Bioceres Crop Solutions Corp’s year-ago sales were $106.8MFor the next quarter, 3 analysts are estimating revenue of $60.27M. There is a high estimate of $63.5M for the next quarter, whereas the lowest estimate is $54.5M.
A total of 2 analysts have provided revenue estimates for BIOX’s current fiscal year. The highest revenue estimate was $334.4M, while the lowest revenue estimate was $307.1M, resulting in an average revenue estimate of $320.75M. In the same quarter a year ago, actual revenue was $333.3MBased on 1 analysts’ estimates, the company’s revenue will be $378.7M in the next fiscal year. The high estimate is $378.7M and the low estimate is $378.7M.
